Section 5
Chapter 4,663

Activated complement in the sputum from patients with cystic fibrosis

Schiøtz, P.O.; Sørensen, H.; Høiby, M.

Acta Pathologica et Microbiologica Scandinavica. Section C Immunology 87c(1): 1-5


ISSN/ISBN: 0304-1328
PMID: 433601
Accession: 004662020

Download citation:  

Cystic fibrosis (CF) patients (14) chronically infected with mucoid Pseudomonas aeruginosa and presenting multiple precipitins in serum against this bacterium (CF + P), and 13 CF patients without P. aeruginosa infection (CF-P) had their plasma and sputum sol phase examined for albumin. C1q [q fragment of complement component 1], C3/C3c, C4 and C5 by means of electroimmunoassays. Their sputum sol phase was examined for factor B by rocket immunoelectrophoresis. C3c was demonstrated in the sputum sol phase, but was significantly more frequent (P < 0.01) among the CF + P patients than among the CF-P patients. Factor .hivin.B was demonstrated in the sputum sol phase, but no significant difference in frequency could be demonstrated between the CF + P and the CF-P patients. None of the results indicated that a local pulmonary production of complement factors took place. C activation was significantly (P < 0.01) associated with inflammation expressed as increased sputum sol phase albumin:plasma albumin ratio. C-mediated inflammation is important in the pathogenesis of pulmonary tissue damage in patients with CF. Chronic P. aeruginosa lung infection may be an immune complex disease in CF patients.

Full Text Article emailed within 1 workday: $29.90